SCHEMBL19009529

SCHEMBL19009529

c1ccc(-c2nc(-c3ccccc3)nc(-c3ccc(-c4ccc(-c5ccccn5)cc4)cc3)n2)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.59
TDP1 Q9NUW8 2/20 0.59
RAB9A P51151 5/20 0.57
SMN1; SMN2 Q16637 4/20 0.57
TP53 P04637 4/20 0.57
LMNA P02545 3/20 0.57
ALDH1A1 P00352 2/20 0.57
MAPT P10636 2/20 0.57
HPGD P15428 2/20 0.57
PKM P14618 2/20 0.57
TSHR P16473 1/20 0.57
KLF5 Q13887 1/20 0.57
HSD17B10 Q99714 1/20 0.57
NPC1 O15118 3/20 0.54
MEN1 O00255 3/20 0.53
KMT2A Q03164 3/20 0.53
CCR1 P32246 2/20 0.50
CCR5 P51681 2/20 0.50
CCR8 P51685 2/20 0.50
CYP1A2 P05177 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2252937 1.00 KDM4E (0.59) KDM4ETDP1RAB9ASMN1; SMN2TP53
SCHEMBL2757062 1.00 KDM4E (0.59) KDM4ETDP1RAB9ASMN1; SMN2TP53
SCHEMBL2253669 1.00 KDM4E (0.59) KDM4ETDP1RAB9ASMN1; SMN2TP53
SCHEMBL19039940 1.00 KDM4E (0.59) KDM4ETDP1RAB9ASMN1; SMN2TP53
SCHEMBL17932570 1.00 KDM4E (0.59) KDM4ETDP1RAB9ASMN1; SMN2TP53
SCHEMBL17598584 0.98 KDM4E (0.61) KDM4ETDP1RAB9ASMN1; SMN2TP53
SCHEMBL17932569 0.94 KDM4E (0.67) KDM4ETDP1RAB9ASMN1; SMN2TP53
SCHEMBL2946874 0.93 KDM4E (0.52) KDM4ETDP1RAB9ASMN1; SMN2TP53
SCHEMBL17598683 0.93 KDM4E (0.52) KDM4ETDP1RAB9ASMN1; SMN2TP53
SCHEMBL2945305 0.93 KDM4E (0.52) KDM4ETDP1RAB9ASMN1; SMN2TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11329230-B2 Organic light-emitting device SAMSUNG DISPLAY CO., LTD. (KR) 2022-05-10 US disclosed
EP-3246963-A2 ORGANIC LIGHT-EMITTING DEVICE Samsung Display Co., Ltd. (KR) 2017-11-22 EP disclosed
US-20170179402-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2017-06-22 US disclosed
US-20170179402-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2017-06-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11329230-B2 Organic light-emitting device EML4, SUN2, TRPA1 KDM4E 2540/4885TDP1 3082/4885RAB9A 1433/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.